Operating cash flow increased 27.0%
Operating cash flow changed +27.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$12.5M→-$9.1M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AVXL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding increased 7.9%
Shares outstanding changed +7.9% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
85,893,834→92,696,8427 prior comparisons
Operating income changed across a sign change
Operating income changed +146.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$14.5M→$6.7M2 prior comparisons
Net income changed across a sign change
Net income changed +159.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
-$13.2M→$7.8M2 prior comparisons
Cash & equivalents increased 17.0%
Cash & equivalents changed +17.0% from the comparable as-filed period.
$101.2M→$118.3M3 prior comparisons
Total assets increased 17.3%
Total assets changed +17.3% from the comparable as-filed period.
$102.4M→$120.1M3 prior comparisons
Stock-based compensation changed across a sign change
Stock-based compensation changed -495.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$4.3M→-$17.1M2 prior comparisons
Cash & equivalents increased 9.1%
Cash & equivalents changed +9.1% from the comparable as-filed period. The change ranks at the 38th percentile of 84 prior comparable changes.
$120.8M→$131.7M84 prior comparisons
Stock-based compensation decreased 46.1%
Stock-based compensation changed -46.1% from the comparable as-filed period. The change ranks at the 58th percentile of 91 prior comparable changes.
$2.1M→$1.1M91 prior comparisons
Research & development decreased 55.4%
Research & development changed -55.4% from the comparable as-filed period. The change ranks at the 58th percentile of 117 prior comparable changes.
$10.4M→$4.7M117 prior comparisons
Operating income increased 50.1%
Operating income changed +50.1% from the comparable as-filed period. The change ranks at the 61th percentile of 46 prior comparable changes.
-$13.6M→-$6.8M46 prior comparisons
Operating cash flow increased 41.0%
Operating cash flow changed +41.0% from the comparable as-filed period. The change ranks at the 54th percentile of 50 prior comparable changes.
-$12.1M→-$7.2M50 prior comparisons
Net income increased 53.1%
Net income changed +53.1% from the comparable as-filed period. The change ranks at the 63th percentile of 128 prior comparable changes.
-$12.1M→-$5.7M128 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.